The Supreme Court’s approval of the Affordable Care Act leads the panelists into a discussion about how healthcare reform will affect the coverage of treatment modalities such as immunotherapy.
Although it remains unclear how the new system will affect cancer care, Daniel George, MD, believes that patients will benefit.
Jeffrey Weber, MD, PhD, explains that under “Obamacare” fewer patients will be uninsured. As a result, practitioners will be able to see and treat more patients.
The panelists agree that under the new system professionals will be able to treat patients with immunotherapy because patients will now have coverage to receive treatment. Before, immunotherapy was not always an option.
Additionally, Dr Weber explains that healthcare reform should not affect smaller practices any differently from larger practices. However, the panelists agree that it will be necessary under the new care system that any issues of wasteful spending be addressed, as this is currently extremely common.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
From Red Tape to Relief: Rewriting the Rules of Prior Authorization
June 23rd 2025Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.
Read More
Culture Key to Data Collection of Sexual Orientation and Gender Identity in Cancer Care
June 23rd 2025This research highlights the key factors, like leadership buy-in, mandatory protocols, and electronic health record workflows, that influence the effective collection of data on sexual orientation and gender identity in outpatient oncology clinics to improve patient-centered care.
Read More